Shares of AxoGen Inc. (AXGN) have lost over 28% from their 52-week high of $10.83, recorded in February of this year, and trade around $7.
The company is focused on developing and marketing innovative surgical solutions that are used primarily by hand surgeons, reconstructive plastic surgeons, and oral and maxillofacial surgeons in a wide variety of peripheral nerve injuries.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com